Shannon Tarman
About Shannon Tarman
Shannon Tarman is a Clinical Account Executive at ANI Pharmaceuticals, Inc. in San Diego County, California, with extensive experience in the pharmaceutical industry, including roles at Mallinckrodt Pharmaceuticals and UCB.
Work at ANI Pharmaceuticals
Shannon Tarman has been employed at ANI Pharmaceuticals, Inc. as a Clinical Account Executive since 2022. In this role, she operates within San Diego County, California, focusing on managing clinical accounts and fostering relationships with healthcare providers. Her responsibilities include implementing strategies that align with the company's objectives and enhancing patient access to medications.
Previous Experience in Pharmaceuticals
Prior to her current position, Shannon Tarman held various roles in the pharmaceutical industry. She worked as an Executive Sales Specialist for Autoimmune and Rare Diseases at Mallinckrodt Pharmaceuticals from 2013 to 2018. Before that, she served as a Specialty Account Manager at Horizon from 2019 to 2022. Her extensive background also includes positions at UCB as a CNS District Manager and at Biogen Idec as an Area Business Manager.
Education and Expertise
Shannon Tarman earned a Bachelor of Arts degree from California State University, Chico, where she studied from 1988 to 1992. Her educational background supports her expertise in clinical account management. She is skilled in networking and territory analytics, which contribute to her effectiveness in her current role. Additionally, she emphasizes patient-centric selling and exceptional customer service.
Career Progression in the Pharmaceutical Industry
Shannon Tarman's career in the pharmaceutical industry spans several decades, beginning with her role as a Respiratory Representative at Rhone-Poulenc Rorer from 1994 to 1997. She later worked at Human Genome Sciences as a Senior Account Manager from 2010 to 2012. Her diverse experience across various companies and roles has equipped her with a comprehensive understanding of the industry and its dynamics.